Home / Learn / Cancer Types / Hematologic Malignancies / All Hematologic ACCCBuzz Articles

All Hematologic ACCCBuzz Articles

We welcome you to share our blog content. We want to connect people with the information they need. We just ask that you link back to the original post and refrain from editing the text. Any questions? Email Maddelynne Parker, Content Manager.

FROM THE ACCCBUZZ BLOG

Achieving Excellence in Oncology Care: A Journey to Regional QOPI® Certification
Nicole A. Colwell, MD
September 09, 2024
In a noteworthy quality improvement initiative, Advocate Health and Hospitals Corporation/Advocate Medical Group in Illinois has achieved a regional Quality Oncology Practice Initiative (QOPI®) certification.
CAR T-Cell Therapy: A Significant Advance for Patients with Hematologic Malignancies
By Nicole Tapay, JD
November 15, 2023
As CAR T-cell therapies provide new treatment options for patients with certain hematologic malignancies, it is important that more cancer centers and programs deliver them.
Improving Care Delivery for Transplant-Ineligible Patients with Acute Myeloid Leukemia
October 24, 2023
ACCC in partnership with HealthTree Foundation for Acute Myeloid Leukemia, has launched an education program to explore the current barriers in care coordination and therapy options for patients with AML who are not eligible for transplant.
Regional Disparities in Chronic Lymphocytic Leukemia: A GPS for Cancer Care
June 22, 2023
ACCC set out to identify and understand specific regional challenges to appropriate and equitable care for patients with chronic lymphocytic leukemia, the most common form of leukemia in adults.
Managing Side Effects and Nutritional Needs for Patients with Myelofibrosis
April 27, 2023
ACCCBuzz spoke with Dr. Gabriela Hobbs, MD, at Massachusetts General Hospital Cancer Center to learn how to best manage patients' care for those with myelofibrosis.
The Psychosocial and Financial Aspects of Treating Myelofibrosis
April 11, 2023
ACCCBuzz spoke with Julie Huynh-Lu, PA-C—physician assistant in the Department of Leukemia at the University of Texas MD Anderson Cancer Center—to learn more about enhancing the care for patients with myelofibrosis by assessing and addressing their psychosocial and financial health.
ACCC Recognizes Multiple Myeloma Awareness Month
March 21, 2023
March is Multiple Myeloma Awareness Month. Learn more about the work ACCC is doing to support oncology professionals in treating patients with this disease.
Triplet vs. Quadruplet Therapy: Choosing the Right Multiple Myeloma Treatment
November 23, 2022
ACCCBuzz spoke with Dr. Jessica Unzaga at Baptist Health’s Miami Cancer Institute, to help consider the use of triplet vs. quadruplet regimens in the treatment of multiple myeloma.
Integrating Oral Oncolytics into Chronic Lymphocytic Leukemia Practice
October 07, 2022
With the treatment of chronic lymphocytic leukemia (CLL) shifting substantially in the last five years, learn how ACCC is supporting oncology professionals in integrating oral oncolytics in CLL practice.
Multiple Myeloma: Considering First-Line Treatment Options
September 28, 2022
ACCCBuzz spoke with Dr. Dan Vogl to learn more about the treatment options available to patients with multiple myeloma, including the benefits of adding anti-CD38 monoclonal antibodies in either first- or second-line treatment.
The Impact of Oncology Financial Advocacy: A Patient Story
July 14, 2022
Allen Beck and Rivka Beck were newly weds when Allen was diagnosed with myelodysplastic syndrome. A month before he was scheduled to complete a bone marrow transplant, he lost the insurance coverage provided by his university. Angie Santiago, CRCS, the manager of Oncology Financial Advocacy at Sidney Kimmel Cancer Center at the Thomas Jefferson University Health System in Philadelphia, Pa, made sure he was able to get the health insurance coverage he needed to complete his treatment.
MRD Testing in Multiple Myeloma
By Eva Pan, PharmD, BCOP
July 05, 2022
Measurable residual disease (MRD) has gained traction as a compelling marker for disease status across various hematologic malignancies, including multiple myeloma. Learn how MRD is uniquely suited to help evaluate the depth of treatment response.
MRD Testing in Chronic Lymphocytic Leukemia
By Eva Pan, PharmD, BCOP
June 29, 2022
With data already demonstrating the role of MRD for CLL response assessment and prognosis, cancer programs should prepare themselves for implementation of MRD testing for appropriate patients.
The Promise of MRD Testing in Hematologic Malignancies
May 05, 2022
Testing for measurable residual disease can shape treatment choices and patient management to achieve better outcomes, and the need persists for members of the multidisciplinary cancer care team to better understand the purpose, use, and significance of this testing in all cancer treatment settings.
Expanding Awareness of Multiple Myeloma
March 23, 2022
March is Multiple Myeloma Awareness Month. Learn how ACCC is supporting collaboration among healthcare providers with practical, scalable solutions to the real-world challenges of improving quality care delivery for patients with multiple myeloma.
Multiple Myeloma & Colin Powell
November 22, 2021
The vulnerability of patients with multiple myeloma has received special attention lately due to the recent passing of former Secretary of State General Colin Powell related to complications from COVID-19.
ACCC Recognizes Blood Cancer Awareness Month
September 16, 2021
With projects that address acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), B-Cell ALL, and hematology disease education, ACCC is developing new resources for cancer programs and practices that focus on multidisciplinary approaches to caring for patients with blood cancer.
Cancer Survivors Share Their Stories
June 15, 2021
Moving Immunotherapy Patients Into Survivorship: A Conversation
December 11, 2020
Recent advances in immuno-oncology (IO) therapies have led to rapid, effective treatments for subsets of patients with cancers that have proven resistant to conventional treatments.
Lessons Learned From Cancer Patients
April 07, 2020
Staying Connected in an Uncertain Time
March 20, 2020
How Targeted Therapies are Affecting the Cancer Care Team: A Conversation With Dr. Firas El Chaer
January 21, 2020
Targeting the Patient as Consumer for Better Outcomes
January 06, 2020
September is Blood Cancer Awareness Month
September 10, 2019
Specific Age-Related Challenges of an ALL Diagnosis
Meredith Barnhart, LCSW-R
April 04, 2019
Incorporating Health Literacy in ALL Patient Education
Mohamed Hersi, PharmD, BCPS
February 14, 2019
Minimal Residual Disease in Adult ALL
Michael J. Borowitz, MD, PhD
February 11, 2019
The Art of Managing ALL
Sandra Kurtin, PhD, ANP-C, AOCN
February 05, 2019
Life, Interrupted: One AYA Patient's Cancer Journey
By Amanda Patton, ACCC
October 31, 2016

View all ACCBuzz Blog articles

Share

In This Section

All Hematologic ACCCBuzz Articles

FROM THE ACCCBUZZ BLOG